Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Hikma Pharmaceuticals PLC - London-based pharmaceutical company - Reports that Bassam Kanaan, executive vice president of corporate development and M&A, sold 35,000 shares at 1,960 pence each for £686,000 on Thursday. He subsequently sold 10,000 shares at 2,025p each for £202,500. Proceeds for the disposals total £888,500. Both transactions took place on the London Stock Exchange.
Current stock price: 1,998.55p, down 0.2% in London on Tuesday morning
12-month change: down 6.9%
Copyright 2024 Alliance News Ltd. All Rights Reserved.